Arava (Leflunomide) – Patient Guide (UK)

Arava is the brand name of leflunomide, a medicine used to treat certain long-term inflammatory conditions, particularly rheumatoid arthritis and psoriatic arthritis. This guide explains how Arava works, how it’s taken, what to expect, and important safety information for people in the United Kingdom.

Always follow the instructions provided with your medicine. Your healthcare team may tailor the dose, monitoring schedule, and treatment plan to your needs.

Quick overview

• Medicine: Arava (leflunomide)
• Use: Long-term treatment for inflammatory arthritis
• Type: Disease-modifying anti-rheumatic drug (DMARD)
• How it’s taken: Usually by mouth once daily
• Key safety needs: Regular blood tests and monitoring of liver health
• Important: Not suitable in pregnancy; requires effective contraception

Basic product information

How Arava works (mechanism of action)

Leflunomide is a disease-modifying anti-rheumatic drug. After taking Arava, the body converts leflunomide into an active metabolite (primarily A771726). This metabolite helps slow down immune activity involved in inflammatory joint disease.

In particular, leflunomide reduces formation of pyrimidines (building blocks for DNA and RNA) by inhibiting an enzyme called dihydroorotate dehydrogenase. This can limit proliferation of immune cells and reduce inflammation, helping to:

• reduce joint swelling and pain
• improve function and quality of life
• slow disease progression over time

Pharmacokinetics: how your body handles Arava

Understanding how long the medicine stays in the body can be helpful, especially if you need to stop treatment temporarily or if you have planned pregnancy.

• Absorption: Leflunomide is absorbed from the gut; the active metabolite is formed after absorption.
• Protein binding: The active metabolite binds to blood proteins, contributing to a long-lasting effect.
• Half-life: The active metabolite can remain in the body for a long time (sometimes months) if not cleared using a specific “washout” procedure.
• Elimination: The active metabolite is eliminated mainly through metabolism and excretion; because of its long presence, special clearing steps may be recommended in certain situations.
• Implications for safety: If Arava is stopped, its effects may persist due to the long retention of the active metabolite.

What Arava is used for (indications)

Arava is used to treat inflammatory arthritis conditions, including:

• Rheumatoid arthritis (RA): Helps reduce symptoms and slow progression.
• Psoriatic arthritis (PsA): Particularly in active disease, often where an oral DMARD is appropriate.

Your healthcare team will confirm the exact condition and treatment plan that applies to you.

Typical timing and when you may feel effects

Arava is not a fast-acting “pain-reliever.” It is intended for long-term disease control.

• Initial period: Some people notice benefits after a few weeks, but it often takes longer.
• More established response: Improvements may become clearer after several months of consistent use.
• During early treatment: Your doctor may also use other therapies (such as anti-inflammatory medicines) to help control symptoms while Arava takes effect.

Consistency matters: Taking Arava at the same time each day can help you stay on track with long-term therapy.

Dosing: how Arava is usually taken

Dosing can vary depending on your diagnosis, disease severity, and blood test results. It is important to follow the dose and instructions provided by your clinician.

Common dosing approaches (general overview):

• Loading approach (sometimes used): Some patients start with a higher dose for a short period to reach effective levels more quickly, followed by a maintenance dose.
• Maintenance dosing: After the initial period, Arava is typically continued once daily at a maintenance dose.

How to take:

• Take the tablet(s) with water.
• Try to take it at the same time each day.
• If you miss a dose, do not take a double dose. Contact your pharmacist or healthcare team for advice.

Regular monitoring is part of treatment: Blood tests are used to detect side effects early, particularly those affecting the liver and blood cells.

Food interactions: can you take Arava with meals?

Arava is generally taken as a daily oral dose. Many people can take it with or without food, but absorption and tolerability can vary between individuals.

• If you experience stomach upset: Taking Arava with food may help.
• Avoid large changes: Don’t make sudden changes to your diet just to “improve” the medicine effect without discussing it with your clinician.

Tip: For most patients, the key is routine—take it the same way each day (either always with food or always without), unless advised otherwise.

Alcohol interactions and liver safety

Leflunomide can affect the liver. Because alcohol also affects the liver, the combination may increase the risk of liver injury.

• Alcohol: It is generally recommended to limit alcohol or avoid it, especially if you have existing liver problems or abnormal liver blood tests.
• Watch for symptoms of liver problems: Seek urgent medical advice if you notice yellowing of the skin/eyes, dark urine, severe nausea/vomiting, or unusual fatigue.

Practical approach: Ask your healthcare team what amount of alcohol (if any) is safe for you. The answer may depend on your test results and overall health.

Medicine interactions (important drug interaction points)

Arava can interact with a range of medicines. Always inform your healthcare team about all medicines you take, including over-the-counter products, herbal supplements, and vaccines (especially live vaccines).

Commonly relevant interaction categories

• Other liver-affecting medicines: Combining Arava with other drugs that can stress the liver may increase risk.
• Immunosuppressants: Arava may change infection risk when used alongside other immune-modifying treatments.
• Warfarin (and similar anticoagulants): There may be effects on blood clotting control; close monitoring is needed if used together.
• Vaccines: Some vaccines may be less suitable during immunomodulatory therapy. Discuss vaccination plans with your clinician.
• Herbal supplements: Some supplements may affect liver enzymes or immune function. Avoid starting supplements without advice.

Tell your clinician if you take any of the following (examples)

• methotrexate
• other DMARDs or biologic therapies
• strong anti-inflammatory medicines or corticosteroids
• anticoagulants (e.g., warfarin)
• medicines that affect the immune system

Key message: Do not start, stop, or change dose of any other medicine while on Arava without checking compatibility.

Safety profile: side effects and what to watch for

Like all medicines, Arava can cause side effects. Many people tolerate it well, but important risks require monitoring.

Common side effects

• Gastrointestinal symptoms: nausea, diarrhoea, abdominal discomfort
• Skin issues: rash (sometimes mild)
• Infections: increased susceptibility, especially if combined with other immune treatments
• Headache

Serious side effects (seek medical advice promptly)

• Liver problems: jaundice, dark urine, persistent vomiting, right upper abdominal pain
• Blood disorders: unusual bruising, persistent sore throat, mouth ulcers, fevers or infections that don’t settle
• Severe skin reactions: widespread rash, blistering, peeling skin, or mouth sores
• Lung symptoms: new or worsening cough, breathlessness, or chest pain—report these promptly
• Severe allergic reactions: swelling of face/lips, trouble breathing, or collapse

Pregnancy and fertility (very important)

Leflunomide must be used with extreme caution because it can harm an unborn baby. Arava is generally not suitable during pregnancy. Because of the long-lasting active metabolite, pregnancy planning requires specific guidance and sometimes a washout (clearing) procedure before conception.

• Contraception: Effective contraception is usually required during treatment and for a time after stopping, as advised by your healthcare team.
• Planning pregnancy: Discuss plans early to allow time for safe clearance.
• If pregnancy occurs: Seek urgent medical advice immediately to discuss next steps.

Breastfeeding

Use during breastfeeding may not be recommended. Speak to your healthcare team about risks and alternatives.

Kidney concerns

Arava is mainly handled by the body’s processes rather than kidney filtration alone. Your clinician may still monitor safety and adjust based on your overall health.

Practical use tips for patients

• Keep up with blood tests: Monitoring typically includes liver function and full blood count. Don’t skip appointments.
• Know your baseline: Keep copies of results if you can, and track them if your clinic uses a shared record.
• Hydrate and protect your stomach: If you experience nausea or diarrhoea, tell your clinician. Simple measures may help, but persistent symptoms should be reviewed.
• Report infections early: Fever, persistent cough, or unusual symptoms should be discussed promptly.
• Sun/skin awareness: If you get a rash, let your healthcare team know—especially if it spreads or worsens.
• Use a medication routine: Consider a daily alarm, pill organiser, or habit pairing (e.g., after breakfast).
• Carry a medicine list: In case of emergency, your list helps clinicians manage interactions safely.

Stopping Arava: what you should know

If Arava is stopped, the active metabolite can persist for a long time. This has consequences for:

• side effect duration
• pregnancy planning
• starting another immune-modifying therapy

If stopping is necessary for safety reasons, your clinician may recommend a washout procedure to help clear the active metabolite faster.

Alternative options for rheumatoid arthritis and psoriatic arthritis

There are several other treatments for RA and PsA, and the “best” option depends on your disease pattern, previous responses, risk factors, and preferences.

Common alternatives include

• Methotrexate (another widely used DMARD)
• Sulfasalazine (DMARD often used for arthritis)
• Hydroxychloroquine (DMARD, sometimes for milder disease)
• Biologic DMARDs (e.g., TNF inhibitors or other targeted therapies)
• Targeted synthetic DMARDs (e.g., JAK inhibitors—eligibility depends on individual risk factors)
• Corticosteroids and NSAIDs for symptom relief (not DMARDs, used short-term/bridging in many cases)

Your rheumatology team can explain which options best match your circumstances.

UK market and legal context (how Arava fits into the NHS and UK medicines landscape)

In the United Kingdom, medicines like Arava are supplied through community pharmacies and hospital services depending on your care pathway. In many cases, DMARDs are managed through specialist services such as rheumatology clinics, with ongoing monitoring coordinated between primary and secondary care.

Key points relevant to UK patients:

• Regulatory standards: Medicines in the UK are authorised and monitored through the medicines regulator.
• Safety monitoring culture: Regular blood tests for DMARDs are standard practice.
• Shared records: Many clinicians use electronic health records to track monitoring and results.
• Supply considerations: Availability may vary due to manufacturing or distribution factors; pharmacies aim to minimise delays.

This information is general. Your care pathway may be different depending on NHS local processes or private healthcare arrangements.

Recent guidance and monitoring practices (what to expect)

Clinical guidance for RA and PsA commonly focuses on:

• early disease control to reduce long-term joint damage
• regular monitoring for treatment safety and effectiveness
• shared decision-making about risks and benefits
• vaccination and infection risk awareness before and during immunomodulatory treatment

In practice, for leflunomide/Arava, you can generally expect:

• baseline blood tests before starting (or soon after)
• follow-up blood tests at scheduled intervals
• review of symptoms (skin, stomach, infection, breathing)
• dose adjustments based on results and tolerance

If your healthcare team changes the monitoring schedule, follow their plan.

Delivery and availability (UK)

Arava availability can depend on the specific tablet strength and stock levels at supplier and pharmacy level. When ordering through an online pharmacy, typical delivery expectations in the UK include:

• Home delivery: Most online pharmacies provide tracked delivery to UK addresses.
• Packaging: Medicines are delivered in appropriate protective packaging to help maintain safety and integrity.
• Dispatch times: Dispatch may vary depending on whether the product is in stock.
• Out-of-stock plans: If a tablet strength is temporarily unavailable, the pharmacy may offer an alternative strength where appropriate or notify you about expected delivery timing.

Availability and delivery times can vary. Check the product page details for current estimates.

FAQ about Arava (Leflunomide)

1. How long does Arava take to work?

It’s a slow-acting DMARD. Some people may notice benefits in a few weeks, but clearer improvement often takes several months. Your clinician may use other medicines to control symptoms while waiting for full effect.

2. Can I take Arava with food?

Many people can take Arava with or without food. If you feel nausea or stomach upset, taking it with food may help. Keep the routine consistent unless your healthcare team advises changes.

3. Is it safe to drink alcohol while taking Arava?

Because leflunomide can affect the liver, alcohol can increase liver-related risk. It’s usually recommended to limit alcohol or avoid it, especially if you have liver test abnormalities. Discuss your personal alcohol intake with your healthcare team.

4. What blood tests will I need?

Monitoring typically includes liver function tests and full blood counts. The frequency varies by your clinic and risk factors. Follow the schedule you’re given and don’t skip tests.

5. What should I do if I miss a dose?

Do not take a double dose. Contact your pharmacist or healthcare team for advice on what to do next.

6. What side effects are most important to report urgently?

Seek prompt medical advice for signs such as yellowing of the skin/eyes, severe or worsening rash, breathing problems, persistent fever or infections, unusual bruising, or severe abdominal symptoms.

7. Can I take other medicines with Arava?

Some combinations are unsafe or require close monitoring. Tell your clinician and pharmacist about everything you take—including over-the-counter medicines and herbal products—so they can check for interactions.

8. Can I use Arava if I’m trying for a baby?

Arava is not typically suitable during pregnancy, and because it can remain in the body for a long time, pregnancy planning needs specialist guidance. Talk to your clinician well in advance about safe stopping and any clearance (“washout”) steps.

9. Do I need a washout procedure if I stop Arava?

Sometimes yes, depending on the reason for stopping (for example, planning pregnancy or certain safety concerns). This is individual and should be guided by your healthcare team.

10. What alternative treatments might be considered?

Alternatives for RA/PsA can include other DMARDs (such as methotrexate, sulfasalazine, hydroxychloroquine) and targeted biologic or targeted synthetic therapies. Choice depends on your disease activity and your medical history.

Summary

Arava (leflunomide) is an oral DMARD used to manage rheumatoid arthritis and psoriatic arthritis. It works by modulating immune activity to help control inflammation and slow disease progression. Treatment requires regular blood monitoring and careful attention to liver health, infections, and possible skin or lung symptoms. Arava has an important safety consideration in pregnancy planning due to how long it can remain in the body.

If you have questions about suitability, monitoring schedules, or how to take Arava safely, speak to a qualified healthcare professional or your pharmacy team.